Healthcare is the foundation of human progress—without it, communities cannot thrive, economies cannot grow, and dreams cannot take flight. Yet across many parts of Kenya and East Africa, access to quality healthcare and reliable pharmaceuticals remains limited. Pabari Group is committed to changing this reality, driving healthcare accessibility and innovation through its two flagship companies: GHPL (Get Well Hospital Pharma Ltd) and Doctor Pharma Kenya Limited.
Expanding Access Through Community Clinics
GHPL (Get Well Hospital Pharma Ltd) is Pabari Group’s network of outpatient clinics, designed to bring affordable, quality healthcare closer to communities. Currently operating in three key towns across Kenya, GHPL clinics deliver primary care, preventive services, diagnostics, and outpatient treatments under one roof.
Each clinic is staffed by qualified medical professionals who are passionate about patient well-being and guided by Pabari’s strong governance and operational excellence. GHPL’s model integrates with Pabari’s pharmaceutical supply chain to ensure affordable medicines, steady availability, and reliable service—addressing one of the biggest challenges in the region’s healthcare system.
By reducing travel distances, wait times, and treatment costs, GHPL is closing the healthcare access gap for underserved populations and setting the stage for national expansion.
Local Manufacturing with Global Expertise
While GHPL strengthens healthcare delivery, Doctor Pharma Kenya Limited enhances the pharmaceutical supply chain by focusing on local manufacturing, marketing, and international medical tourism services.
A division of Doctor Pharma Manufacturing UK Ltd (Berkshire, United Kingdom), the company leverages global pharmaceutical expertise to develop and distribute high-quality, cost-effective medicines tailored to the Kenyan market. Managed by a skilled team in Nairobi and Mumbai, Doctor Pharma also facilitates medical tourism by connecting Kenyan patients to world-class hospitals and specialists abroad, ensuring they receive advanced treatments not available locally.
This combination of local production and international healthcare linkages gives Doctor Pharma a unique position to boost local capacity while providing global-standard care to patients.
Creating Impact Through Vertical Integration
Pabari Group’s strategy links healthcare delivery and pharmaceutical supply, creating a vertically integrated model that reduces costs, ensures consistent quality, and improves access. This model not only strengthens Kenya’s healthcare ecosystem but also offers high-value investment opportunities for partners and stakeholders who want to support sustainable health infrastructure.
Both GHPL and Doctor Pharma are aligned with Kenya’s universal health coverage goals—delivering innovation, efficiency, and compassionate care to communities that need it most.
Pabari Group’s investments in healthcare and pharmaceuticals go beyond business—they are about building healthier communities, empowering lives, and transforming the future of healthcare in Kenya and East Africa. Through GHPL and Doctor Pharma Kenya Limited, we are nurturing a healthier, more resilient society—one patient at a time.
